Status:
UNKNOWN
Clinical Study of Qingpeng Ointment in Treating Shoulder Syndrome During Rehabilitation Period of Cerebral Hemorrhage
Lead Sponsor:
Guangzhou University of Traditional Chinese Medicine
Conditions:
The Efficacy of Qingpeng Ointment
Eligibility:
All Genders
20-80 years
Phase:
PHASE4
Brief Summary
A randomized, controlled study is conducted. 120 patients with post-stroke shoulder-shoulder syndrome who meet the inclusion criteria are randomized into treatment group and control group, 60 patients...
Eligibility Criteria
Inclusion
- Meet the diagnostic criteria for stroke;
- Meet the diagnostic criteria for shoulder-hand syndrome, stage I
- The course of disease is between 15 days and 6 months;
- Consciousness, no serious cognitive impairment, with examination and treatment;
- Age between 20 and 80 years old;
- Sign the informed consent form and volunteer to participate in the study.
Exclusion
- Repeated stroke patients or shoulder-hand syndrome patients with repeated attacks or exacerbations;
- The course of stroke is \>6 months;
- Those with serious heart, liver and kidney diseases and moderate to severe infections;
- Unconsciousness or a combination of incompetent cognitive impairment and complete aphasia.
- Take painkillers or other treatments that treat shoulder pain.
Key Trial Info
Start Date :
March 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04039737
Start Date
March 1 2017
End Date
December 31 2019
Last Update
September 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong Provincial Hospital of Chinese medicine
Guangzhou, Guangdong, China, 510120